Picture of Insulet logo

PODD Insulet Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Annual cashflow statement for Insulet, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line11.66.816.84.6206
Depreciation
Non-Cash Items78.685.212153.757.2
Unusual Items
Other Non-Cash Items
Changes in Working Capital-19.7-63.4-264-2.5-191
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities98.484-68.1119146
Capital Expenditures-171-167-123-157-109
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items97.318140-33.8-10.2
Acquisition of Business
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-73.614-82.7-191-119
Financing Cash Flow Items-8.6-32-32.2-16.8-13.5
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities73.560640.7-40.3-13.6
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash99.8708-116-11714.5